23andMe has raised a substantial $115 million in a series E round led by Fidelity Management and Research Company, with participation from new investors Casdin Capital, WuXi Healthcare Ventures, and Xfund, as well as existing investors such as Google Ventures.
The personal genomics and biotechnology company was founded in 2006 by Linda Avey and Anne Wojcicki, wife of Google cofounder Sergey Brin. The Mountain View, Calif.-based company had already raised $126 million prior to today’s announcement, and boasts a slew of big-name investors, including Google, Google Ventures, Sergey Brin, and Yuri Milner.
{iframe}http://venturebeat.com/2015/10/14/23andme-raises-115m-to-grow-its-dna-health-test-technology-globally/?utm_source=feedburner&utm_medium=email&utm_campaign=Feed:+Venturebeat+(VentureBeat){/iframe}